BusinessAmpio Prescription drugs to Host Enterprise Replace Name with...

Ampio Prescription drugs to Host Enterprise Replace Name with Chairman and CEO Mike Martino on Wednesday, Dec. 1

-

- Advertisment -
- Advertisement -


ENGLEWOOD, Colo., Nov. 29, 2021 /PRNewswire/ — Ampio Prescription drugs (NYSE American: AMPE), a biopharmaceutical firm centered on the development of immunology-based therapies for prevalent inflammatory situations, in the present day introduced it is going to host a enterprise replace name with its chairman and CEO, Mike Martino, at 4:30 p.m. EST on Wednesday, Dec. 1, 2021. Traders and analysts can entry by way of the data supplied beneath:

Massive Prescription drugs Brand. (PRNewsFoto / Ampio Prescription drugs, Inc.) (PRNewsfoto / Ampio Prescription drugs, Inc.)

Webcast Hyperlink:
https://occasion.on24.com/wcc/r/3543501/784479B739F2EB467C477016E7FAD06A

Convention Name (pay attention solely)

Canada dial-in quantity (Toll Free):

1 833 950 0062

Canada dial-in quantity (Native):

1 226 828 7575

United States:

1 844 200 6205

United States (Native):

1 646 904 5544

All different places:

1 929 526 1599

Entry code:

948260

*Contributors might want to enter the participant entry code earlier than being met by an operator

With the intention to submit questions, contributors should have Web connectivity, as questions will solely be addressed by way of the webcast. The convention name line will probably be in listen-only mode.

The convention name and webcast can be accessed from the Investor Relations part of the Firm’s web site at www.ampiopharma.com and will probably be archived there shortly after the dwell occasion.

About Ampio Prescription drugs

Ampio Prescription drugs, Inc. is a biopharmaceutical firm primarily centered on the development of immunology-based therapies to deal with prevalent inflammatory situations for which there are restricted remedy choices. Ampio’s lead drug, Ampion™, is backed by an in depth patent portfolio with mental property safety extending via 2037 and could also be eligible for 12-year FDA market exclusivity upon approval as a novel biologic beneath the Biologics Value Competitors and Innovation Act (BPCIA).

Ahead Trying Statements

Ampio’s statements on this press launch that aren’t historic truth, and that relate to future plans or occasions, are forward-looking statements inside the that means of the Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements may be recognized by means of phrases resembling “imagine,” “anticipate,” “plan,” “anticipate,” and related expressions. These forward-looking statements embody statements concerning Ampio’s expectations with respect to Ampion and its classification, in addition to these related to regulatory approvals and different FDA choices, the Organic License Utility (BLA), the power of Ampio to enter into partnering preparations, scientific trials and choices and adjustments in enterprise situations and related occasions, the power to obtain regulatory approval to conduct scientific trials, that Ampion could also be used to deal with ARDS induced by COVID-19, all of that are inherently topic to numerous dangers and uncertainties. The dangers and uncertainties concerned embody these detailed once in a while in Ampio’s filings with the Securities and Change Fee, together with with out limitation, beneath Ampio’s Annual Report on Kind 10-Ok and different paperwork filed with the Securities and Change Fee. Ampio undertakes no obligation to revise or replace these forward-looking statements, whether or not because of new data, future occasions or in any other case.

Investor and Media Contacts:

Tony Russo or Nic Johnson
Russo Companions
information@ampiopharma.com
tony.russo@russopartnersllc.com
nic.johnson@russopartnersllc.com

Cision

Cision

View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-to-host-business-update-call-with-chairman-and-ceo-mike-martino-on-wednesday-dec-1-301433202.html

SOURCE Ampio Prescription drugs, Inc.

- Advertisement -

Latest news

Bruce Campbell Shares Hilarious, Bogus Idea Attempting To Improve Earnings For Spider-Man 4

Bruce Campbell, who starred in Sam Raimi's Evil Ineffective sequence and has manufactured cameos in almost all the...

Future actions within the Houston area

Profession lookup social gathering hosted by...

A Wrestling Advertising Is Altering From Reside Motion To Animation

That’s a various approach to present issues. Certified wrestling has been throughout for a fairly extended time now...
- Advertisement -
- Advertisement -

You might also likeRELATED
Recommended to you